Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM
Mirati Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| License and Collaboration Revenue Revenue | 11.72M |
| License and Collaboration Revenue Revenue Growth | n/a |
| Product Revenue Revenue | 713K |
| Product Revenue Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 72M | 75.49M | 73.49M | 70.82M | 60.8M | 54.23M | 53.95M | 43.53M | 35.18M | 29.61M | 28.35M | 25.34M | 20.25M | 19.78M | 18.05M | 12.23M | 10.69M | 9.89M | 9.76M | 6.37M | 5.31M | 4.84M | 5.15M | 2.98M | 3.12M | 3.65M | 3.69M | 3.9M | 3.48M | 3.79M | 4.13M | 3.58M | 4.16M | 4.24M | 3.78M |
| Selling, General, and Administrative Revenue Growth | -4.62% | +2.72% | +3.77% | +16.49% | +12.12% | +0.51% | +23.93% | +23.74% | +18.82% | +4.45% | +11.89% | +25.13% | +2.38% | +9.60% | +47.54% | +14.47% | +7.99% | +1.35% | +53.18% | +19.95% | +9.75% | -6.07% | +72.78% | -4.36% | -14.64% | -1.06% | -5.33% | +12.26% | -8.21% | -8.33% | +15.52% | -14.08% | -1.86% | +12.20% | n/a |
| Research and Development Revenue | 114.77M | 124.19M | 126.68M | 141.24M | 131.08M | 128.34M | 130.98M | 153.84M | 116.11M | 134.57M | 104.07M | 82.7M | 79.85M | 65.08M | 71.71M | 62.94M | 47.36M | 38.32M | 34.24M | 26.76M | 23.63M | 23.83M | 19.66M | 15.24M | 13.48M | 14.96M | 14.4M | 15.95M | 16.11M | 18.44M | 17.99M | 14.91M | 14.56M | 11.28M | 8.21M |
| Research and Development Revenue Growth | -7.59% | -1.97% | -10.30% | +7.75% | +2.13% | -2.01% | -14.86% | +32.50% | -13.72% | +29.31% | +25.83% | +3.57% | +22.69% | -9.24% | +13.93% | +32.89% | +23.58% | +11.93% | +27.96% | +13.26% | -0.85% | +21.21% | +28.96% | +13.07% | -9.89% | +3.92% | -9.75% | -0.96% | -12.66% | +2.52% | +20.62% | +2.40% | +29.15% | +37.39% | n/a |